Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Propagation behaviour of peripheral amyloid-β towards brain structures: effects of the blood-brain barrier

PROP-AD

Alzheimer's disease is a disease in which specific peptides, so-called beta-amyloids, accumulate in the brain, leading to the destruction of neurons and the resulting clinical functional effects, e.g. memory and orientation problems. Discussions are ongoing as to whether or not Alzheimer's disease may be transmissible between individuals and could...

Funding Programme
Start Date
End Date
Total Funding
€ 1 746 751
European Countries Involved

Research to Assess Policies and Strategies for Dementia in the Young

RHAPSODY

Dementia is 60 times less common in people aged below 65 years than in older adults. However, when dementia occurs at a relatively young age it imposes a particularly severe burden on patients and families. RHAPSODY attempts to improve the management of young-onset dementia across Europe. The project starts with an analysis how health and social...

Funding Programme
Start Date
End Date
Total Funding
€ 1 805 985
European Countries Involved

Risk and Modifying factors in Fronto Temporal Dementia

RiMod-FTD

Fronto-Temporal-Dementia (FTD) is a devastating progressive early onset dementia with a strong genetic influence. Currently, seven genes have been identified that explain >50% of familial cases, but how these different genes lead to a very similar clinical phenotype is still an unanswered question. Currently, there is no cure for FTD and for the...

Funding Programme
Start Date
End Date
Total Funding
€ 3 190 796
European Countries Involved

Self-management and HeAlth Promotion in Early-stage dementia with e-learning for carers – A randomised controlled trial

SHAPE

We will develop and validate an intervention (SHAPE) in 330 people with mild dementia; combining self-management, health promotion, and e-learning. The study is a multi-site, randomised, controlled, single-blinded trial with parallel groups. The intervention group is compared with treatment as usual (TAU). The primary outcome is to evaluate the...

Funding Programme
Start Date
End Date
Total Funding
€ 2 887 000
European Countries Involved

Social Health And Reserve in the Dementia patient journey

SHARED

The role of social health in onset, disease course and prognosis of dementia remains underexplored. Social health has been conceptualized as the influence of social resources in finding a balance between capacities and limitations. Moreover, social health affects and is affected by biological processes that underlie the dementia syndrome. This...

Funding Programme
Start Date
End Date
European Countries Involved

Subjective cognitive decline in preclinical Alzheimer’s Disease: European initiative on harmonization and on a lifestyle-based prevention strategy

EURO-SCD

Subjective cognitive decline (SCD) in elderly individuals with still normal cognitive performance is considered an at-risk condition of Alzheimer's disease (AD) dementia and may reflect its first symptomatic manifestation. This makes SCD a promising target for dementia prevention trials. This project aims at creating a transnational, harmonized...

Funding Programme
Start Date
End Date
Total Funding
€ 834 697
European Countries Involved

Synapse-to-nucleus communication in Alzheimer’s disease

STAD

Understanding how fast events at synapses are converted into long-lasting changes of neuronal acti- vity is a very important question in neuroscience. Several recent studies demonstrated that synapses and nuclei are connected by bidirectional communication routes that enable the efficient transfer of information and regulate the long-term...

Funding Programme
Start Date
End Date
Total Funding
€ 838 087
European Countries Involved

Synaptic circuit protection in Alzheimers’s disease (AD) and Huntingtion’s disease (HD): BDNF/TrkB and Arc signaling as rescue factors

CircProt

Alzheimer´s (AD) and Huntington´s disease (HD) result from the erroneous communication of neurons at synapses in different brain areas (neocortex, hippocampus, striatum). The protein BDNF regulates synaptic communication under healthy conditions. However, insufficient release of BDNF from neurons and defective BDNF signaling in target neurons...

Funding Programme
Start Date
End Date
European Countries Involved

Targeting epigenetic dysregulation in the brainstem in Alzheimer’s disease

EPI-AD

We aim to elucidate the exact role of epigenetic dysregulation in the brainstem in the pathogenesis of AD. For this purpose, we will examine post-mortem brainstem tissue derived from AD patients, and matched controls, for epigenetic differences. By investigating AD-specific epigenetic profiles in the blood of individuals suffering from Mild...

Funding Programme
Start Date
End Date
European Countries Involved

Targeting the propagation of pathogenic protein assemblies in neurodegenerative disease

NeuTARGETS

Similar to prion diseases, more common fatal neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease are linked to the aggregation of different proteins (including Tau, Abeta and alpha- synuclein in the brain of affected patients. Furthermore most of the resulting brain lesions initially appear in specific brain areas and the...

Funding Programme
Start Date
End Date
Total Funding
€ 1 369 544
European Countries Involved

The effects of an extensive exercise program on the progression of mild cognitive impairment (MCI)

NEUROEXERCICE

Epidemiological studies have shown that leisure-time physical activity at midlife is associated with a decreased risk of dementia later in life. Although initial studies indicate enhanced behavioural performance in dementia patients after three months of exercise, little is known about the effect of an extensive, controlled and regular exercise...

Funding Programme
Start Date
End Date
Total Funding
€ 1 395 100
European Countries Involved

The interplay of amyloid and ischemia and their influence on the blood-brain barrier, amyloid transportation systems and neurodegeneration in cerebral amyloid angiopathy (CAA)

SNOWBALL

Several studies have shown that ischemic stroke, a result of an occluded vessel in the brain, could be followed by cognitive decline and, after several strokes, lead to dementia, similar to Alzheimer’s disease but with a different clinical presentation, especially in the beginning. We believe that there is cross-talk between vessel occlusion and...

Funding Programme
Start Date
End Date
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).